Patients With Stable CAD May Not Benefit From Adding an ACE ...

"Patients with stable coronary artery disease (CAD) do not benefit from the addition of an angiotensin-converting enzyme (ACE) inhibitor, particularly trandolapril, according to the results of a randomized study published in the Nov. 11 issue of the New England Journal of Medicine."